Royalty Amounts. Abrika shall pay to Corium the following royalties during the Term of this Agreement: I
Royalty Amounts. During the Royalty Term for each Sole Development Product commercialized by the Developing Party under ARTICLE VI, the Developing Party will pay the Discontinuing Party a royalty on Net Sales of such Sole Development Product (except to the extent otherwise provided under Section 7.5(b)) at the following rates:
Royalty Amounts. Subject to Section 4.2(a), during the Royalty Period, Licensee shall pay to Licensor, within forty-five (45) days following each calendar quarter in a year beginning April 1 and ending March 31 (a “Contract Year”) or portion thereof during the Term, the following royalty fee (“Royalty Fee”): Net Sales Royalty Less than Ten Million Dollars ($10,000,000) Zero percent (0%) of Net Sales Between Ten Million Dollars ($10,000,000) and Twenty Million Dollars ($20,000,000) Seven percent (7%) of Net Sales More than Twenty Million Dollars ($20,000,000) Ten percent (10%) of Net Sales A Royalty Fee calculation example is attached hereto as Exhibit D.
Royalty Amounts. Diomed hereby agrees to pay to HRI at the address specified by QLT from time-to-time on behalf of QLT (with a statement setting out such payments delivered to QLT simultaneously with such payments to HRI) a royalty of:
Royalty Amounts. Subject to the terms and conditions of this Agreement, in consideration of the rights and licenses granted herein, the Licensee shall pay to the Licensor a royalty equal to [**Confidential Treatment Requested] percent ([**Confidential Treatment Requested]%) of Gross Sales (collectively, the “Royalty”).
Royalty Amounts. In consideration of the license .granted herein and for the Term of this License Agreement, Licensee will pay to uOttawa; in the manner designated in this. License Agreement; as earned royalty, the amounts set out -in Schedule “B”. Licensee will pay any royalties due and payable on Net Sales-and. Sublicensing Revenue within 60 days after Royalty Due Date for the twelve month period immediately ending on the applicable Royalty Due Date. All amounts due to uOttawa under this License Agreement are in Canadian dollars and are to be paid. in Canadian dollars. With respect to sales of Licensed Products invoiced in a currency other than Canadian dollars, the ‘Net Sales and royalties and other payments payable hereunder shall be expressed in the domestic currency of the party making the sale together with the Canadian dollar equivalent of the royalty payable, and such exchange shall be determined based on, the average of the Canadian dollar equivalent exchange rate as reported in the United States Federal Reserve Statistical Release: Foreign Exchange Rates, available on-line at xxxx://xxxxxxxxxxxxxx.xxx/releases/ for the first and last business day for the calendar quarter in which the transaction occurs.
Royalty Amounts. Sublicensee shall pay to Sublicensor earned royalties as follows:
Royalty Amounts. Licensee will pay Akebia nonrefundable and noncreditable royalties based on Net Sales of the Licensed Product in the Territory during the Royalty Term at the applicable incremental royalty rates set forth in Table 9.3.1 for Net Sales of the Licensed Product (“Royalty Payments”). Net Sales for all countries will be aggregated for purposes of calculating the applicable royalty tier for Net Sales. Table 9.3.1 – Royalty Rates Portion of Annual Net Sales (in U.S. Dollars) of the Licensed Product in the Territory Royalty Rate 0 to ≤ €[**] 10% >€[**] to ≤ €[**] [**]% >€[**] to ≤ €[**] [**]% >€[**] 30%
Royalty Amounts. In the case of Products distributed through the Release Point of Sale Network, Distributor will pay Vendor a royalty in accordance with the Point of Sale Network Royalty Schedule set forth in Exhibit C and, in the case of the distribution of Products through the Publisher Direct Program, Distributor will pay Vendor a royalty in accordance with the Publisher Direct Royalty Schedule set forth in Exhibit C (collectively referred to herein as the "Royalty" or "Royalties"), provided that no Royalty shall be owed for: (a) copies of the Products [***] = CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. returned to Distributor for refund in accordance with the End User License Agreement or Section 3.2, or because of defects or errors, regardless of source; or (b) chargeback transactions (except as expressly provided in Section 6.2 below).
Royalty Amounts. In consideration of the license granted herein and for the Term of this License Agreement, Licensee will pay to Institution, in the manner designated in this License Agreement, as earned royalty, the amounts set out in Schedule “B” attached to this License Agreement.
